Skip to main content
. 2022 Apr 7;14(8):1858. doi: 10.3390/cancers14081858

Table 5.

Cutoff values for stratifying patients into low- and high-risk groups of each risk model.

Risk Model Cutoff Range IQR
Radiomics_DCE_MR 1.118
Development 0.298–1.118 0.755–0.789
Validation 0.325–1.794 0.875–0.927
Radiomics_Perfusion 1.043
Development 0.594–1.337 0.908–0.922
Validation 0.611–1.327 0.892–0.915
HRS-only 1.067
Development 0.322–1.691 0.823–1.255
Validation 0.396–1.533 0.872–1.181
Clinical 0.318
Development 0.170–1.816 0.170–0.654
Validation 0.170–2.216 0.318–0.723
Combined habitat 1.867
Development 0.337–16.442 0.981–4.327
Validation 0.321–22.717 1.132–5.186